Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart. Published Online First: 5 November 2009. doi:10.1136/hrt.2009.184507
Copyright © 2009 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2009;0:hrt.2009.184507
© 2009 by BMJ Publishing Group & British Cardiac Society

Original Article

Coronary Collateral Growth by External Counterpulsation: A Randomized Controlled Trial

Steffen Gloekler, Pascal Meier, Stefano F de Marchi, Tobias Rutz, Tobias Traupe, Stefano F Rimoldi, Kerstin Wustmann, Hélène Steck, Stéphane P Cook, Rolf Vogel, Mario Togni, Christian Seiler*

1 Cardiology, University Hospital Bern, Switzerland

Correspondence to: Christian Seiler, Cardiology, University Hospital, Freiburgstrasse, Bern, CH-3010, Switzerland; christian.seiler{at}insel.ch

Accepted 20 October 2009

ABSTRACT

Background: The efficacy of external counterpulsation (ECP) on coronary collateral growth has not been investigated in a controlled randomized study.

Methods: In 20 patients with chronic stable coronary artery disease (CAD), the hypothesis was tested that ECP augments collateral function during a 1-minute coronary balloon occlusion. Before and after 30 hours of randomly allocated ECP (20 90-minute sessions over 4 weeks at 300mmHg inflation pressure) or sham ECP (same setting at 80mmHg inflation pressure), invasive collateral flow index (CFI, no unit) was obtained in 34 vessels without coronary intervention. CFI was determined by the ratio of mean distal coronary occlusive to mean aortic pressure both subtracted by central venous pressure. Additionally, coronary collateral conductance (occlusive myocardial blood flow per aorto-coronary pressure drop) was determined by myocardial contrast echocardiography, and brachial artery flow-mediated dilation (FMD) was obtained.

Results: CFI changed from 0.125 (0.073; interquartile range) at baseline to 0.174 (0.104) at follow-up in the ECP group (p=0.006), and from 0.129 (0.122) to 0.111 (0.125) in the sham ECP group (p=0.14). Baseline to follow-up change of coronary collateral conductance was from 0.365 (0.268) to 0.568 (0.585)ml/min/100mmHg in the ECP group (p=0.072), and from 0.229 (0.212) to 0.305 (0.422) ml/min/100mmHg in the sham ECP group (p=0.45). There was a correlation between the FMD change from baseline to follow-up and the corresponding CFI change (r=0.584, p=0.027).

Conclusions: ECP appears to be effective in promoting coronary collateral growth. The extent of collateral function improvement is related to the amount of improvement in systemic endothelial function.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.